reports
September 1st Deadline Alert: The Law Offices of Howard G. Smith Remin...
BENSALEM, Pa.--(BUSINESS WIRE)-- Law Offices of Howard G. Smith reminds investors of the September 1, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA) securities between April 30, 2013 to May 16, 2017, inclusive (the “Class Period”). Sinovac investors have until September 1, 2017 to file a lead plaintiff motion. Investors suffering losses on their Sinovac investments are encouraged to conta...
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf...
NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sinovac Biotech Ltd. (NASDAQ:SVA) who purchased shares between April 30, 2013 and May 16, 2017. The action, which was filed in District of New Jersey, alleges that the Company violated federal securities laws. In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) Defendant Weidong Yin,...
The Klein Law Firm Announces a Class Action Filed on Behalf of Sinovac...
NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sinovac Biotech Ltd. (NASDAQ: SVA) who purchased shares between April 30, 2013 and May 16, 2017. The action, which was filed in District of New Jersey, alleges that the Company violated federal securities laws. In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) Defendant Weid...
SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors ...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in District of New Jersey on behalf of investors who purchased Sinovac Biotech Ltd. ("Sinovac Biotech Ltd.") (NASDAQ:SVA) securities between April 30, 2013 and May 16, 2017. Click here to learn about the case: http://www.wongesq.com/pslra-sb/sinovac-biotech-ltd?wire=2. There is no cost or obligation to you. According to the complaint, throughout the Class Period, the Company issued materially fal...
SVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Invest...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in District of New Jersey on behalf of investors who purchased Sinovac Biotech Ltd. ("Sinovac Biotech Ltd.") (NASDAQ:SVA) securities between April 30, 2013 and May 16, 2017. Click here to learn about the case: http://www.wongesq.com/pslra-sb/sinovac-biotech-ltd?wire=2. There is no cost or obligation to you. According to the complaint, throughout the Class Period, the Company issued materially fal...
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac ...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sinovac Biotech Ltd. ("Sinovac Biotech Ltd.") (NASDAQ: SVA) between April 30, 2013 and May 16, 2017. You are hereby notified that a securities class action lawsuit has been commenced in District of New Jersey. To get more information go to: http://www.zlk.com/pslra-sba/sinovac-biotech-ltd?wire=2 or contact Joseph E. Levi, Esq. eithe...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sino...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sinovac Biotech Ltd. ("Sinovac Biotech Ltd.") (NASDAQ:SVA) between April 30, 2013 and May 16, 2017. You are hereby notified that a securities class action lawsuit has been commenced in District of New Jersey. To get more information go to: http://www.zlk.com/pslra-sba/sinovac-biotech-ltd?wire=2 or contact Joseph E. Levi, Esq. either...
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses I...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Sinovac Biotech Ltd. (Nasdaq: SVA) (“Sinovac” or the “Company”) securities during the period between April 30, 2013 and May 16, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until September 1, 2017 to seek appo...
The Klein Law Firm Reminds Investors of an Investigation Concerning Po...
NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces the commencement of an investigation of Sinovac Biotech Ltd (NASDAQ:SVA) concerning possible violations of federal securities laws. On December 21, 2016, an article published by SeekingAlpha.com revealed that Sinovac's Chairman and Chief Executive Officer, Weidong Yin, paid bribes to the Deputy Director General of the Center for Drug Evaluation for the China Food and Drug Administration and his wife, to help advance drug applications and evaluations. Sinovac later annou...
The Klein Law Firm Notifies Investors of an Investigation Concerning P...
NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces the commencement of an investigation of Sinovac Biotech Ltd (NASDAQ: SVA) concerning possible violations of federal securities laws. On December 21, 2016, an article published by SeekingAlpha.com revealed that Sinovac's Chairman and Chief Executive Officer, Weidong Yin, paid bribes to the Deputy Director General of the Center for Drug Evaluation for the China Food and Drug Administration and his wife, to help advance drug applications and evaluations. Sinovac later anno...
SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors ...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong reminds investors of an investigation concerning whether Sinovac Biotech Ltd (NASDAQ: SVA) violated federal securities laws. Click here to learn about the case: http://docs.wongesq.com/SVA-Info-Request-Form-1640 There is no cost or obligation to you. On December 21, 2016, an article published by SeekingAlpha.com revealed that Sinovac's Chairman and Chief Executive Officer, Weidong Yin, paid bribes to the Deputy Director General of the Center for Drug Evaluat...
SVA LOSS NOTICE: Rosen Law Firm Reminds Sinovac Biotech Ltd. Investor...
NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Sinovac Biotech Ltd. (NASDAQ:SVA) from April 30, 2013 through May 16, 2017, both dates inclusive (the “Class Period”) of the important September 1, 2017 lead plaintiff deadline in the first filed class action commenced by Rosen Law Firm. The lawsuit seeks to recover damages for Sinovac investors under the federal securities laws. To join the Sinovac class action, go to http://www.rosenlegal.com/cases-1015.html ...
SVA INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong reminds investors of an investigation concerning whether Sinovac Biotech Ltd (NASDAQ: SVA) violated federal securities laws. Click here to learn about the case: http://docs.wongesq.com/SVA-Info-Request-Form-1640 There is no cost or obligation to you. On December 21, 2016, an article published by SeekingAlpha.com revealed that Sinovac's Chairman and Chief Executive Officer, Weidong Yin, paid bribes to the Deputy Director General of the Center for Drug Evaluat...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Inves...
NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of Sinovac Biotech Ltd (NASDAQ: SVA) concerning possible violations of federal securities laws. On December 21, 2016, an article published by SeekingAlpha.com revealed that Sinovac's Chairman and Chief Executive Officer, Weidong Ying, paid bribes to the Deputy Director General of the Center for Drug Evaluation for the China Food and Drug Administration and his wife, to help advance drug applications and evaluations. Sinovac later announce...
SINOVAC LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages...
NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Sinovac Biotech, Ltd. (“Sinovac” or the “Company”) (NASDAQ:SVA) of the September 1, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company., a leading national securities law firm, reminds investors in Sinovac Biotech, Ltd. (“Sinovac” or the “Company”) (NASDAQ:SVA) of the September 1, 2017 deadline to seek the role of lead plaintiff in a federal securities...
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class...
IRVINE, Calif.--(BUSINESS WIRE)-- Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (Nasdaq: SVA). Investors who purchased or otherwise acquired shares between April 30, 2013 and May 16, 2017 inclusive (the “Class Period”), should contact the firm in advance of the September 1, 2017 lead plaintiff motion deadline. If you purchased Sinovac shares during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 18101 Von Karm...
SINOVAC INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who ...
NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ:SVA). The investigation focuses on whether the Company and its executives violated federal securities laws. Specifically, on December 21, 2016, Seeking Alpha published an article stating that the Chairman and CEO of Sinovac, Weidong Ying, paid bribes to Yin Hongzhang, the Deputy Director General of the Center for Drug Evaluation for t...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of the Com...
NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of Sinovac Biotech Ltd (NASDAQ:SVA) concerning possible violations of federal securities laws. On December 21, 2016, an article published by SeekingAlpha.com revealed that Sinovac's Chairman and Chief Executive Officer, Weidong Ying, paid bribes to the Deputy Director General of the Center for Drug Evaluation for the China Food and Drug Administration and his wife, to help advance drug applications and evaluations. Sinovac later announced...
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Aga...
NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Sinovac Biotech Ltd. (NASDAQ: SVA) from April 30, 2013 through May 16, 2017, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Sinovac investors under the federal securities laws. To join the Sinovac class action, go to http://www.rosenlegal.com/cases-1015.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-76...
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Pr...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”) relating to the proposed buyout of Sinovac by Sinovac (Cayman) Limited and Sinovac Amalgamation Sub Limited. Under the terms of the agreement, Sinovac shareholders are anticipated to receive $7.00 in cash for each shar...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.